Cyclooxygenase inhibition and cardiovascular risk.
Antman
Elliott M
EM
Cardiovascular Division, Department of Medicine, Brigham & Women's Hospital, 75 Francis St, Boston, MA 02115, USA. eantman@rics.bwh.harvard.edu
DeMets
David
D
Loscalzo
Joseph
J
D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced / Q000453:epidemiology; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors